Zydus Pharmaceuticals Inc, USA, a fully-owned subsidiary of Cadila Healthcare (Zydus Cadila), has signed a license and supply deal with CHEMI SpA for launching the generic version of Sanofi Aventis’s Lovenox (Enoxaparin Sodium Injection) in the US. The generic equivalent of Enoxaparin Sodium Injection has been launched in seven dosage strengths. Enoxaparin Sodium Injection is […]
Zydus Cadila (Cadila Healthcare) said that it has secured the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D vaccine for Covid-19 for adults and also adolescents in the age group of 12-18 years. According to Zydus Cadila, ZyCoV-D is the first Plasmid DNA vaccine for Covid-19 in the world. […]
Zydus Cadila said that it has secured final approval from the US Food and Drug Administration (FDA) to market Mesalamine Extended-Release Capsules in the strength of 0.375g. Mesalamine Extended-Release capsules are approved for the maintenance of remission of ulcerative colitis in adult patients. Zydus Cadila said that the ulcerative colitis drug will be manufactured at […]
Cadila Healthcare (also known as Zydus Cadila) said that it has secured tentative approval from the US Food and Drug Administration (FDA) for marketing Pemetrexed for Injection in 100mg/vial, 500mg/vial, and 1000mg/vial, single-dose vials. Pemetrexed for Injection is the generic for Eli Lilly and Company (Lilly) owned Pemetrexed, which is sold under Alimta and other […]
Cadila Healthcare (also known as Zydus Cadila) said that it has secured tentative approval from the US Food and Drug Administration (FDA) to market Brivaracetam Tablets in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg. Brivaracetam is approved for the treatment of partial-onset of seizures (epilepsy). Zydus Cadila will […]
Cadila Healthcare (also known as Zydus Cadila) said that it has adopted a new technology initiative called ‘Zydus Verify’ to protect patients against counterfeit drugs. In this connection, the Indian pharma company has rolled out a new feature in the packaging of its critical drugs for helping patients in identifying whether the product is genuine […]
Cadila Healthcare (also known as Zydus Cadila) said that it has secured final approval from the US Food and Drug Administration (FDA) to market Fluphenazine Hydrochloride Tablets 1 mg, 2.5 mg, 5 mg, and 10 mg. The reference listed drug (RLD) of Zydus Cadila’ Fluphenazine Hydrochloride Tablets is Prolixin Tablets, which are indicated for the […]
Cadila Healthcare (also known as Zydus Cadila) has signed a license supply and commercialization agreement with Taiwanese pharma company TLC to commercialize the latter’s Black Fungus drug – AmphoTLC (Amphotericin B Liposome for Injection 50mg) in India. As per the terms of the deal, TLC will manufacture and supply AmphoTLC on a non-exclusive basis to […]
Zydus Cadila has secured restricted emergency use approval for ‘Virafin’, Pegylated Interferon alpha-2b (PegIFN) from the Drug Controller General of India (DCGI) for the treatment of moderate Covid-19 infection in adult patients. According to the Indian pharma company, a single dose subcutaneous regimen of Virafin will make the treatment more easier for the patients. When […]